Companies › CPHI

CHINA PHARMA HLDGS INC (CPHI)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001106644 · EDGAR filings · Updated 2026-07-23

CHINA PHARMA HLDGS INC (CPHI) has reported institutional ownership of 0.1%, with 6 institutional managers holding positions valued at $15.7K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-23 — Prospectus supplement (424B5) filed
• 2026-07-22 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-05-15 — Quarterly report (10-Q) filed
• 2026-04-01 — Annual report (10-K) filed
• 2026-04-01 — Late-filing notice for annual report (NT 10-K)
• 2026-03-03 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CHINA PHARMA HLDGS INC has 6 institutional holders and institutional ownership of 0.1%.

Data flags from SEC filings

Related companies

BON NATURAL LIFE LIMITED (BON) · ADITXT INC (ADTX) · CYTOMED THERAPEUTICS LIMITED (GDTC) · BIOTRICITY INC (BTCY) · SYNLOGIC INC (SYBX) · SciSparc Ltd (SPRC)